The city will receive $110,953 minus a 25% fee that goes to attorneys from Endo Pharmaceuticals' settlement with the State of Alabama. Attorney General's Office - State of Alabama (Reuters) - Alabama is set to take drug distributor McKesson Corp and pharmaceuticals maker Endo International Plc to trial over claims they fueled the opioid epidemic as the state fights for a multi-billion dollar payout after rejecting a nationwide settlement. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); The change you are requesting will be linked to this page. Are We Seeing an End to Opioid Litigation? State of Alabama Related: Drug overdoses climbed in Alabama during pandemic, Opioid crisis roars back in Alabama as overdoses rise during pandemic, Opioid overdose deaths rise among Blacks; one Birmingham mother an inspiring model for recovery. The states alleged that Endo filed patent infringement suits against Watson after Watson sought FDA approval of a generic version of Lidoderm. Create a NAAG account to subscribe to our newsletters or mailing lists. For Endo: Carole Rendon of BakerHostetler. As the court knows, the state has completed a settlement with Endo, the other defendant, McKesson said in a written statement. CV-2019-901174. (Reuters) - Alabama has resolved claims against drugmaker Endo International Plc over its alleged role in the opioid epidemic and is in settlement talks with distributor McKesson Corp, putting on hold a trial of the state's case against the two companies that was set to begin Monday. The state in its complaint says the companies are responsible for burdening it with the increasing monetary and societal costs of responding to the effects of the opioid epidemic and should be forced to pay billions of dollars to remedy the public nuisance they have created. 05-cv-3450, United States ex rel. 2023 Advance Local Media LLC. Alabama reaches settlement with Endo over opioid claims; McKesson also The state is one of eight that opted to not settle with McKesson, who along with rivals AmerisourceBergen and Cardinal Health agreed in July to pay $21 billion to resolve thousands of opioid lawsuits by other states and local governments. A report today by Reuters included Alabama among eight states that were not committed to participating in a settlement thats expected to involve more than 40 states. or probate matters (real estate, wills, property disputes, etc.). Alabama in the case before Judge J.R. Gaines is seeking a payout that would dwarf what other states would get through that national deal, with the defendants saying the state is asking for damages in the range of $10 billion to $20 billion. Visit this website often to get the most up-to-date information. Endo Announces Execution of Definitive Settlement Agreement and Release Alabama will get nearly $300 million in opioid settlements. How will we Gwengoat/iStock via Getty Images. AG Marshall announces millions in settlements with opioid manufacturers See here for a complete list of exchanges and delays. Attorney General James Secures $50 Million for Opioid Abatement from Detailed information about the Action and the Settlement is contained in the Notice. The state of Alabama has settled with drugmaker Endo International Plc over its alleged role in the opioid epidemic and is now in talks with distributor McKesson Corp. document.getElementById( "ak_js_1" ).setAttribute( "value", ( new Date() ).getTime() ); Sign up here to get the latest news and updates delivered directly to your inbox. Alabama is accusing McKesson of failing to prevent the diversion of opioids for illicit purposes, and accused Endo of engaging in deceptive marketing practices that misrepresented the painkillers benefits and downplayed their addictive risks, according to its court filings. Alabama to get $276 million settlement over opioid epidemic The primary duty of the Attorney General is to serve as legal counsel to Alabama's state agencies, departments, and officers. IMPORTANT UPDATE Alabama Settles Opioid Claims With J&J, McKesson, Endo for $276 Native American tribes in the U.S. have reached settlements worth $590 million over opioids. We take pride in exposing the hypocrisy of corporations, other organizations, and individuals whose actions put innocent people in harms way. Endo is not part of the proposed $26 billion deal, but previously agreed to settle lawsuits by states or counties in New York, Oklahoma, Tennessee, Louisiana and Ohio for more than $111 million. Learn More, 2023 Copyright National Association of Attorneys General. Under the settlement, Endo will pay the states and promises not to enter into similar reverse-payment agreements in the future. Alabama is not a party to the multistate opioid settlements, Mike Lewis, communications director for Marshall, said. Endo, in an October filing, said that Alabama was seeking at least $10 billion to abate the epidemic and public nuisance the state argued [it] created, as well as $1.65 billion in damages stemming for diminished income and sales tax revenues.. Alabama reached a $276 million settlement agreement with Johnson & Johnson, McKesson and Endo Pharmaceutical for their role in the opioid epidemic, the state's attorney general announced on. In accordance with the Courts September 8, 2021 Order, the initial distribution of the net settlement fund took place on October 28, 2021. Alabama et al. The company has said it is considering "strategic alternatives" if it cannot reach a global settlement, and plaintiffs have raised the possibility of Endo filing for bankruptcy. State of Alabama Reaches Settlements with Two Opioid Manufacturers, One This week, Johnson & Johnson doled out $99 million to remove itself from | Alabama is set to get a $276 million payout from Johnson & Johnson, Endo and McKesson as part of an opioid litigation . v. Endo International (Lidoderm) Settlement. Information from the Attorney Generals Office, Tom Sizemore, 'Saving Private Ryan' actor, dies at 61, Montgomery Firefighters Investigating Large Church Fire Near Downtown, Tallassee Man, Woman Charged with Capital Murder in Death of Woman Found in Macon County, Lowndes County deputies searching for missing man, Spotty Showers Today; Severe Threat Friday Morning, Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. The three companies will also pay a combined $40 million in attorneys fees. He can be reached at brendan.pierson@thomsonreuters.com. The industry leader for online information for tax, accounting and finance professionals. On Monday, the Attorney General announced a $1.5 million distribution to the state's district attorneys to invest in drug courts. Drug overdoses climbed in Alabama during pandemic, Buy newspaper front pages, posters and more. Alabama will spend nearly one-third of the $9 million opioid crisis settlement money with McKinsey & Company, on investments in the state's forensic labs, according to the attorney general's office. Attorney General's Office - go to homepage. The breakdown of the settlements are as follows: Endo Pharmaceutical: The State of Alabama and its subdivisions will receive $25 million this year in a lump-sum payment. You can view the Courts Findings of Fact and Conclusions of Law on the Important Documents tab of this website. Endo in October said the state was seeking at least $10 billion to abate the epidemic and public nuisance the state claims they created, as well as $1.65 billion in damages stemming for diminished income and sales tax revenues. Endo is not part of that deal, but previously settled lawsuits with either states or counties in New York, Oklahoma, Tennessee, Louisiana, and Ohio for a total of more than $111 million. Washington, DC 20036, As the nonpartisan national forum for America's state and territory attorneys general and their staff, NAAG provides collaboration, insight, and expertise to empower and champion America's attorneys general. v. Endo International (Lidoderm) complaint 07-19-19 Alabama et al. I agree to be emailed to confirm my subscription to this list, HHS OCR Issues a Bulletin About Online Tracking Technologies and HIPAA, Twentieth Annual Pharmaceutical Compliance Congress Coming April 2023, Alabama Reaches $276 Million in Opioid-Related Settlements, announced that it reached $276 million in settlements. The state of Alabama has settled with drugmaker Endo International Plc over its alleged role in the opioid epidemic and is now in talks with distributor McKesson Corp. Alabama filed a lawsuit against Endo Pharmaceuticals, McKesson Corporation, and other companies in 2019. . See here for a complete list of exchanges and delays. Alabama et al. v. Endo International, No. 3:19-cv-04157 (N.D. Cal. July The Attorney General's Office does not handle any domestic cases (example: child support, child custody, divorce, etc.) Alabama News Network Staff. Terms of the settlement were not immediately available. The State has remaining claims against opioid manufacturers Purdue Pharma, Mallinckrodt and Insys in each of their respective bankruptcy cases. Access unmatched financial data, news and content in a highly-customised workflow experience on desktop, web and mobile. In making that decision, they will be able to review the past two and a half years of work by the Alabama Opioid Overdose and Addiction Council to determine where they money is needed the most. "The state is continuing to work through the mediator to resolve issues with McKesson, and the parties believe that additional time will allow them to complete a settlement and achieve a resolution without the need for a trial.".